Wednesday, July 1, 2026 Live from SEC EDGAR

The Wire Search Saved

···

FilingIndex

AI-powered intelligence over every SEC filing. Search in plain English. Free.

Browse

Sectors
Themes
Search

Data

SEC EDGAR
About

Legal

Privacy
Disclaimer

© 2026 FilingIndex · Data sourced from SEC EDGAR (public domain).Not investment advice.

GANX — Gain Therapeutics, Inc. SEC Filings | FilingIndex

GANXNasdaq

Gain Therapeutics, Inc.

Pharmaceutical Preparations · DE · CIK 1819411

Develops novel small molecule therapeutics for CNS, LSDs, metabolic, and oncology diseases using its Magellan™ platform

+ Watch View on EDGAR ↗

$72M

Market cap

$2.03

Last close

+2.5%

1D

+14.7%

5D

3.8M

Volume

Price · last 40 sessions+6.8%

May 4L $1.59 · H $2.03Jun 30

106

Total filings

Jun 29, 2026

Last filing

12/31

Fiscal year end

All 8-K · 62 10-Q · 16 424B5 · 8 DEF 14A · 5 10-K · 5 DEFA14A · 4 S-1/A · 2 S-1 · 2

424B5424B5Nov 28, 2025 424B5424B5Jul 17, 2025 424B5424B5Jul 15, 2025 424B5424B5Sep 6, 2024 424B5424B5Jun 17, 2024 424B5

Similar companies

Comparable business profile · signals at a glance

ANVSAnnovis Bio, Inc.$75.7M0.0%CCCCC4 Therapeutics, Inc.$431.2M+7.4%ARVNARVINAS, INC.$489.1M+0.2%PLYXPolaryx Therapeutics, Inc.$118.1M+5.1%KYMRKymera Therapeutics, Inc.

424B5

Jun 13, 2024

424B5424B5Nov 24, 2023

424B5424B5Nov 20, 2023

🔥

$7.1B

+4.9%

SIONSionna Therapeutics, Inc.$1.6B+2.4%